English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 45422/58598 (78%)
造訪人次 : 2537219      線上人數 : 239
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: http://libir.tmu.edu.tw/handle/987654321/6739


    題名: Ras/PI3K/Akt 及p38 MAPK/MSK1 在Peptidoglycan刺激巨噬細胞RAW264.7引發環氧酵素-2表現訊息傳遞路徑之角色探討
    Studies on the Roles of Ras/PI3K/Akt and p38 MAPK/MSK1 in the Signaling Pathway of Peptidoglycan-Induced Cyclooxygenase-2 Expression in RAW264.7 Macrophages
    作者: 康如鈞
    Ju-Chiun Kang
    貢獻者: 藥理學研究所
    關鍵詞: 環氧酵素
    巨噬細胞
    PI3K/Akt
    p38 MAPK/MSK1
    peptidoglycan
    COX-2
    macrophages
    日期: 2004
    上傳時間: 2009-09-11 17:32:55 (UTC+8)
    摘要: Peptidoglycan (PGN)革蘭氏陽性菌細胞壁上的主要成份,與大家所
    熟知的革蘭氏陰性菌細胞壁成分lipopolysaccharide (LPS)一樣皆可造成發炎反應的物質,在免疫反應方面扮演著重要的角色。我們先前的研究已知PGN 在RAW 264.7 巨噬細胞誘導環氧化酶-2(cyclooxygenase-2, COX-2)的表現,可經由Ras/Raf-1/ERK 及NF-kB 的訊息傳遞而來(J. Biol. Chem., 279: 20889-20897, 2004)。本論文主要探討主題為Ras/PI3K/Akt 及p38 MAPK/MSK1 在PGN 誘導RAW 264.7巨噬細胞COX-2 蛋白表現中所扮演著的角色。PGN 誘導COX-2 表現會被PI3K抑制劑(wortmannin, LY 294002),Ras 抑制劑manumycin A,Akt 抑制劑1L-6-Hydroxymethyl-chiro-inositol-2[(R)-2-O-methyl-3-octadecyl-
    carbonate](Akt inh.),p38 MAPK 抑制劑(SB 203580)和MSK1 抑制劑(Ro 318220)所抑制。而且PGN 會有時間相關性誘導IKK alpha/beta
    ,p38 MAPK 和MSK1 的活性及Akt Ser473、p65 Ser536 和Ser276 磷酸化的現象。加入manumycin A,LY 294002 及Akt inh.皆可抑制PGN 誘導Akt Ser473 和IKK alpha/beta磷酸化之現象,但是加入了manumycin A, LY 294002 和Akt inh.,並不會抑制PGN 誘導p65 Ser536的磷酸化。此外, p38 MAPK 抑制劑SB 203580 不同的濃度也不會抑制PGN 誘導p65 Ser536 的磷酸化;相反的, p38 MAPK 抑制劑SB203580 和MSK1 抑制劑Ro 318220,卻可以抑制PGN所誘導p65 Ser276磷酸化的現象。我們也利用轉染及報告基因的方法證實wortmannin,LY 294002, Akt inh, SB 203580 及Ro 318220 皆可以抑制由PGN 誘導kB-luciferase 的活性。接著我們更進一步證實PGN 可以依循時間相關性的誘導p85 alpha及Ras 與toll-like receptor 2 (TLR2)的結合。綜合以上的實驗結果,我們可以推測出PGN 可經由Ras/PI3K/Akt 的路徑活化IKK alpha/beta再活化NF-kB 來調控COX-2 蛋白表現,且又可經由p38 MAPK/MSK1這一條路徑經由p65 Ser276 的磷酸化,同樣活化NF-kB 來調控COX-2蛋白表現。
    Peptidoglycan (PGN), a cell wall component of Gram-positive bacteria,can induce multiple similar responses in immune system as same as lipopolysaccharide (LPS) which is well known as a main cell wall component of Gram-negative bacteria caused inflammations. Our previous study shown that PGN induced cyclooxygenase-2 (COX-2) expression via Ras/Raf-1/ERK and NF-B signaling pathway in RAW 264.7 macrophages (J. Biol. Chem., 279:20889-20897, 2004). In this study, we investigated the roles of Ras/PI3K/Akt and p38MAPK/MSK1 on PGN-induced COX-2 expression in RAW 264.7 macrophages. PGN-induced COX-2 expression was inhibited by specific inhibitors of PI3K (wortmannin and LY294002), Ras inhibitor (manumycin A), Akt inh. (1L-6-Hydroxymethylchiro-inositol-2[(R)-2-O-methyl-3-O-octadecylcarbonate], p38 MAPK inhibitor (SB 203580) and MSK1 inhibitor (Ro 318220). Moreover, PGN induced IKK alpha/beta, p38 MAPK and MSK1 activity and increases in phosphorylation of Akt Ser473, p65 Ser536 and Ser276 in a time-depenednt manner. PGN induced increases in phosphorylation of Akt Ser473 and IKK alpha/beta on PGN-induced was inhibited by manumycin A, LY 294002 and Akt inh.. However, manumycin A, LY 294002 and Akt inh. did not inhibit PGN-induced p65 Ser536 phosphorylation. Inversely,PGN-induced p65 Ser276 phosphorylation was reduced by SB 203580 and Ro 318220 in RAW 264.7 macrophages. Moreover, PGN-induced kB-luciferase activity was inhibited by wortmannin, LY 294002, Akt inh., SB 203580 and Ro 318220. Further studies reveals that PGN induced the recruitment of p85 alpha and Ras to Toll-like receptor 2 (TLR2) in time-dependent manner. This propose demonstrate that two pathway
    cross-link between Ras/PI3k/Akt and p38 MAPK/MSK1 to induce
    IKK alpha/beta activity, p65 Ser536 and Ser276 phosphorylation and NF-kB activation, respectively and ultimately induce COX-2 expression in RAW 264.7 macrophages.
    資料類型: thesis
    顯示於類別:[藥學系] 博碩士論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    摘要.doc30KbMicrosoft Word278檢視/開啟
    摘要.pdf756KbAdobe PDF436檢視/開啟
    摘要.ppt141KbMicrosoft Powerpoint199檢視/開啟
    摘要.ps497KbPostscript85檢視/開啟


    在TMUIR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    著作權聲明 Copyright Notice
    • 本平台之數位內容為臺北醫學大學所收錄之機構典藏,包含體系內各式學術著作及學術產出。秉持開放取用的精神,提供使用者進行資料檢索、下載與取用,惟仍請適度、合理地於合法範圍內使用本平台之內容,以尊重著作權人之權益。商業上之利用,請先取得著作權人之授權。

      The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use. Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner.

    • 瀏覽或使用本平台,視同使用者已完全接受並瞭解聲明中所有規範、中華民國相關法規、一切國際網路規定及使用慣例,並不得為任何不法目的使用TMUIR。

      By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in the statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions. Furthermore, users must not use TMUIR for any illegal purposes.

    • 本平台盡力防止侵害著作權人之權益。若發現本平台之數位內容有侵害著作權人權益情事者,煩請權利人通知本平台維護人員([email protected]),將立即採取移除該數位著作等補救措施。

      TMUIR is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff([email protected]). We will remove the work from the repository.

    Back to Top
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋